Vigil Immunotherapy Tolerated Well for Recurrent Ovarian CA Tx – Monthly Prescribing Reference
|
Vigil Immunotherapy Tolerated Well for Recurrent Ovarian CA Tx
Monthly Prescribing Reference HealthDay News — Vigil immunotherapy shows good tolerability for recurrent ovarian cancer patients, and PARP 7, a poly(ADP-ribose) polymerase protein, may play a significant role in survival for ovarian cancer, according to two studies presented at … |
